These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38793775)
1. Optimization of Culture Media and Feeding Strategy for High Titer Production of an Adenoviral Vector in HEK 293 Fed-Batch Culture. Shen CF; Rodenbrock A; Lanthier S; Burney E; Loignon M Vaccines (Basel); 2024 May; 12(5):. PubMed ID: 38793775 [TBL] [Abstract][Full Text] [Related]
2. Low-glutamine fed-batch cultures of 293-HEK serum-free suspension cells for adenovirus production. Lee YY; Yap MG; Hu WS; Wong KT Biotechnol Prog; 2003; 19(2):501-9. PubMed ID: 12675594 [TBL] [Abstract][Full Text] [Related]
3. Culture media selection and feeding strategy for high titer production of a lentiviral vector by stable producer clones cultivated at high cell density. Shen CF; Tremblay S; Sabourin-Poirier C; Burney E; Broussau S; Manceur A; Rodenbrock A; Voyer R; Loignon M; Ansorge S; Gilbert R Bioprocess Biosyst Eng; 2022 Aug; 45(8):1267-1280. PubMed ID: 35758994 [TBL] [Abstract][Full Text] [Related]
4. Optimization and scale-up of cell culture and purification processes for production of an adenovirus-vectored tuberculosis vaccine candidate. Shen CF; Jacob D; Zhu T; Bernier A; Shao Z; Yu X; Patel M; Lanthier S; Kamen A Vaccine; 2016 Jun; 34(29):3381-7. PubMed ID: 27154390 [TBL] [Abstract][Full Text] [Related]
5. Automated dynamic fed-batch process and media optimization for high productivity cell culture process development. Lu F; Toh PC; Burnett I; Li F; Hudson T; Amanullah A; Li J Biotechnol Bioeng; 2013 Jan; 110(1):191-205. PubMed ID: 22767053 [TBL] [Abstract][Full Text] [Related]
6. High-cell-density cultivations to increase MVA virus production. Vázquez-Ramírez D; Genzel Y; Jordan I; Sandig V; Reichl U Vaccine; 2018 May; 36(22):3124-3133. PubMed ID: 29433897 [TBL] [Abstract][Full Text] [Related]
7. Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures. Henry O; Dormond E; Perrier M; Kamen A Biotechnol Bioeng; 2004 Jun; 86(7):765-74. PubMed ID: 15162452 [TBL] [Abstract][Full Text] [Related]
8. Bioreactor productivity and media cost comparison for different intensified cell culture processes. Xu S; Gavin J; Jiang R; Chen H Biotechnol Prog; 2017 Jul; 33(4):867-878. PubMed ID: 27977910 [TBL] [Abstract][Full Text] [Related]
9. High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system. Vázquez-Ramírez D; Jordan I; Sandig V; Genzel Y; Reichl U Appl Microbiol Biotechnol; 2019 Apr; 103(7):3025-3035. PubMed ID: 30796494 [TBL] [Abstract][Full Text] [Related]
10. Process intensification to produce a difficult-to-express therapeutic enzyme by high cell density perfusion or enhanced fed-batch. Särnlund S; Jiang Y; Chotteau V Biotechnol Bioeng; 2021 Sep; 118(9):3533-3544. PubMed ID: 33914903 [TBL] [Abstract][Full Text] [Related]
11. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality. Yang WC; Lu J; Kwiatkowski C; Yuan H; Kshirsagar R; Ryll T; Huang YM Biotechnol Prog; 2014; 30(3):616-25. PubMed ID: 24574326 [TBL] [Abstract][Full Text] [Related]
12. [Hyperosmotic stress and perfusion culture strategies increase the yield of recombinant adenoviral vector produced by HEK 293 cells]. Zhang Z; Bai Z; Liu G; Nie J; Yang Y Sheng Wu Gong Cheng Xue Bao; 2023 Aug; 39(8):3364-3378. PubMed ID: 37622366 [TBL] [Abstract][Full Text] [Related]
13. Fed-batch strategies for intensified rVSV vector production in high cell density cultures of suspension HEK293 cells. Silva CAT; Kamen AA; Henry O Biotechnol Prog; 2024 Sep; ():e3506. PubMed ID: 39286892 [TBL] [Abstract][Full Text] [Related]
14. Identification of optimal flow rate for culture media, cell density, and oxygen toward maximization of virus production in a fed-batch baculovirus-insect cell system. Sharma S; Mahadevan J; Giri L; Mitra K Biotechnol Bioeng; 2023 Dec; 120(12):3529-3542. PubMed ID: 37749905 [TBL] [Abstract][Full Text] [Related]
15. The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process. Nie J; Sun Y; Feng K; Huang L; Li Y; Bai Z Vaccine; 2022 Mar; 40(13):2036-2043. PubMed ID: 35216843 [TBL] [Abstract][Full Text] [Related]
16. Process intensification in fed-batch production bioreactors using non-perfusion seed cultures. Yongky A; Xu J; Tian J; Oliveira C; Zhao J; McFarland K; Borys MC; Li ZJ MAbs; 2019; 11(8):1502-1514. PubMed ID: 31379298 [TBL] [Abstract][Full Text] [Related]
17. Development, optimization, and scale-up of suspension Vero cell culture process for high titer production of oncolytic herpes simplex virus-1. Shen CF; Burney E; Gilbert R; Elahi SM; Parato K; Loignon M Biotechnol J; 2024 Jan; 19(1):e2300244. PubMed ID: 37767876 [TBL] [Abstract][Full Text] [Related]
18. Development and optimization of an adenovirus production process. Kamen A; Henry O J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761 [TBL] [Abstract][Full Text] [Related]
19. Fed-batch CHO cell t-PA production and feed glutamine replacement to reduce ammonia production. Kim DY; Chaudhry MA; Kennard ML; Jardon MA; Braasch K; Dionne B; Butler M; Piret JM Biotechnol Prog; 2013; 29(1):165-75. PubMed ID: 23125190 [TBL] [Abstract][Full Text] [Related]
20. Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells. Figueroa B; Ailor E; Osborne D; Hardwick JM; Reff M; Betenbaugh MJ Biotechnol Bioeng; 2007 Jul; 97(4):877-92. PubMed ID: 17099908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]